Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
2021
Africa
Americas
Western Pacific
Clear all
Type of publications
NITAG documentation
(88)
Systematic reviews (SYSVAC)
(7)
Topics
Available to download in languages
Regions
Africa
(17)
Americas
(64)
Western Pacific
(14)
Europe
(76)
South-East Asia
(2)
Countries
Argentina
(1)
Australia
(11)
Bolivia
(2)
Burkina Faso
(1)
Canada
(16)
Chile
(9)
China
(3)
Nigeria
(1)
Senegal
(2)
Uganda
(12)
United States of America
(36)
Diseases
COVID-19
(95)
Ebola
(1)
Hepatitis B
(1)
Herpes zoster
(1)
HIV / AIDS
(1)
Human papillomavirus (HPV)
(7)
Influenza
(4)
Malaria
(1)
Meningococcal disease
(1)
Pertussis
(2)
Pneumococcal disease
(2)
Poliomyelitis
(2)
Rabies
(1)
Rotavirus
(5)
Tetanus
(2)
Varicella
(1)
Vaccine topics
Acceptance
(2)
Coverage
(1)
Ethical issues
(2)
Target population
Adults
(5)
All age groups
(4)
Children
(3)
Healthcare workers
(1)
Older adults
(3)
Parents/caregivers
(1)
Pregnant women
(4)
Publication date
2021
(95)
2024
(1)
2023
(23)
2022
(79)
2020
(82)
95 results found
2021
∙
NACI, Public Health Agency of Canada
Guidance on the prioritization of key populations for COVID-19 immunization
2021
∙
Kathleen Dooling, ACIP
Implementation considerations for COVID-19 Vaccines
2021
∙
UNITAG
Interim Advisory on the introduction of COVID-19 vaccine booster doses in Uganda
2021
∙
NACI
Interim guidance on booster COVID-19 vaccine doses in Canada
2021
∙
ACIP
Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years
2021
∙
ACIP
Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines
2021
Interim Recommendations on the Use of COVID-19 Vaccines in Nigeria
2021
∙
Sara Oliver, ACIP
Janssen COVID-19 Vaccine - ACIP conclusion
2021
∙
ATAGI
Joint statement on COVID-19 AstraZeneca vaccine advice from ATAGI - 20 May, 2021
2021
∙
ACIP
Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Janssen COVID-19 Vaccine
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register